Valuation: Avantor, Inc.

Capitalization 745.22Cr 640.59Cr 600.1Cr 559.34Cr 1.03TCr 67TCr 1.12TCr 7.02TCr 2.71TCr 32TCr 2.8TCr 2.74TCr 1,15800Cr P/E ratio 2025 *
-14.9x
P/E ratio 2026 * 21x
Enterprise value 1.09TCr 934.87Cr 875.77Cr 816.28Cr 1.51TCr 98TCr 1.64TCr 10TCr 3.96TCr 46TCr 4.08TCr 3.99TCr 1,69000Cr EV / Sales 2025 *
1.67x
EV / Sales 2026 * 1.6x
Free-Float
96.65%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
Manager TitleAgeSince
Chief Executive Officer 55 18/08/2025
Director of Finance/CFO 55 07/08/2023
Compliance Officer 57 01/07/2023
Director TitleAgeSince
Chairman 67 12/05/2022
Director/Board Member 60 01/09/2019
Director/Board Member 59 22/04/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.97%-6.82% - - 745.22Cr
-0.26%-2.96%+8.20%+20.43% 22TCr
-0.62%-3.77%+20.65%+31.50% 13TCr
+0.60%-7.93%+39.54%+100.60% 6.59TCr
+0.10%-0.03%-11.84%-20.64% 5.54TCr
+0.25%+1.92%+17.82%+76.38% 5.2TCr
+0.87%-1.13%+21.95%+43.42% 2.58TCr
+0.37%+3.18%-15.74%-43.94% 2.55TCr
-0.33%+2.89%+18.63%-34.55% 2.41TCr
-2.23%-2.91%-23.08%+19.35% 2.25TCr
Average -0.32%-1.76%+8.46%+21.39% 6.26TCr
Weighted average by Cap. -0.19%-2.48%+12.03%+28.44%
See all sector performances

Financials

2025 *2026 *
Net sales 652.58Cr 560.95Cr 525.49Cr 489.8Cr 904.67Cr 59TCr 984.02Cr 6.15TCr 2.37TCr 28TCr 2.45TCr 2.4TCr 1,01400Cr 653.86Cr 562.05Cr 526.52Cr 490.76Cr 906.45Cr 59TCr 985.95Cr 6.16TCr 2.38TCr 28TCr 2.45TCr 2.4TCr 1,01600Cr
Net income -50Cr -43Cr -40Cr -38Cr -69Cr -4.51TCr -76Cr -471.75Cr -182.15Cr -2.13TCr -187.98Cr -183.97Cr -7.78TCr 35Cr 30Cr 28Cr 26Cr 48Cr 3.13TCr 52Cr 327.92Cr 126.62Cr 1.48TCr 130.67Cr 127.88Cr 5.41TCr
Net Debt 342.34Cr 294.27Cr 275.67Cr 256.94Cr 474.58Cr 31TCr 516.21Cr 3.22TCr 1.25TCr 15TCr 1.28TCr 1.26TCr 53TCr 297.99Cr 256.15Cr 239.96Cr 223.66Cr 413.1Cr 27TCr 449.34Cr 2.81TCr 1.08TCr 13TCr 1.12TCr 1.09TCr 46TCr
More financial data * Estimated data
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
More about the company
Date Price Change Volume
05/25/05 10.93 $ -1.97% 1,00,45,590
04/25/04 11.15 $ -1.24% 87,39,009
03/25/03 11.29 $ -3.01% 1,12,05,573
02/25/02 11.64 $ -0.94% 56,66,630
01/25/01 11.75 $ +0.17% 76,11,219

Delayed Quote Nyse, December 06, 2025 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
10.93USD
Average target price
13.64USD
Spread / Average Target
+24.82%
Consensus

Quarterly revenue - Rate of surprise